# 外周介入市场

> 外周介入市场研究报告按介入类型（动脉切除术、支架植入、血管成形术、血栓切除术、栓塞）、按设备类型（导管、支架、导丝、气球、栓塞线圈）、按适应症（冠状动脉疾病、中风、外周动脉疾病、肾动脉狭窄、颈动脉狭窄）、按技术（药物洗脱支架、气球扩张支架、自扩张支架、旋转动脉切除术、定向动脉切除术）、按最终用户（医院、门诊手术中心、诊所、研究机构）以及按地区（北美、欧洲、南美、亚太、中东和非洲） - 增长与行业预测2025至2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 7.77%
- **2024:** $ 7.05 Billion
- **2025:** $ 7.6 Billion
- **2035:** $ 16.05 Billion
- **Key Players:** Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Cook Medical (US), Cardinal Health (US), Johnson & Johnson (US), Philips (NL)

**Report ID:** MRFR/HC/28431-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** October 22, 2026

**URL:** https://www.marketresearchfuture.com/reports/peripheral-intervention-market-30173

---

## Market Summary

## **Peripheral Intervention Market Overview**

As per MRFR analysis, the Peripheral Intervention Market Size was estimated at 7.05 (USD Billion) in 2024. The Peripheral Intervention Market Industry is expected to grow from 7.60 (USD Billion) in 2025 to 14.90 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 7.77% during the forecast period (2025 - 2034).

### **Key Peripheral Intervention Market Trends Highlighted**

The global peripheral intervention market exhibits several notable trends influencing its growth trajectory. Firstly, technological advancements in minimally invasive procedures, such as endovascular interventions, are driving the increased adoption of peripheral intervention devices and techniques. Advancements in imaging and navigation systems further enhance the accuracy and safety of these procedures, fostering market growth.Moreover, the rising prevalence of chronic diseases such as cardiovascular disease, diabetes, and peripheral artery disease fuels the demand for peripheral intervention solutions. These diseases often require interventions to address arterial blockages, valve dysfunction, or other vascular abnormalities.

Additionally, the increasing geriatric population with age-related vascular issues contributes to the market demand.

Another key trend is the expansion of peripheral intervention applications beyond traditional cardiovascular indications. Peripheral intervention techniques are now employed in fields such as neurointervention, oncology, and pulmonology. This diversification of applications opens up new avenues for market growth and innovation.Finally, the growing emphasis on patient-centric care and cost-effectiveness is shaping the peripheral intervention market. Patients increasingly demand less invasive and more cost-effective treatment options. Peripheral intervention devices and procedures offer such advantages, driving their adoption by healthcare providers and patients alike.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Peripheral Intervention Market Drivers**

### Technological Advancements Driving Market Growth

The Global Peripheral Intervention Market Industry is witnessing significant growth due to ongoing advancements in medical technology. These advancements have led to the development of more precise and less invasive peripheral intervention devices. For instance, the introduction of robotic-assisted peripheral intervention systems has enhanced the accuracy and efficiency of procedures, reducing the risk of complications.

Additionally, the use of 3D imaging techniques, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), has improved visualization and guidance during peripheral interventions, leading to better patient outcomes.Furthermore, the development of bioresorbable stents and other innovative devices is expected to further drive market growth in the coming years.

### Rising Prevalence of Peripheral Artery Disease (PAD)

The increasing prevalence of peripheral artery disease (PAD) is a major factor driving the growth of the Global Peripheral Intervention Market Industry. PAD is a condition characterized by the narrowing or blockage of arteries in the legs, arms, or neck. It is a common condition, particularly among the elderly population. As the global population ages, the number of individuals affected by PAD is expected to rise, leading to a corresponding increase in the demand for peripheral intervention procedures.This has created a significant opportunity for market growth.

### Growing Adoption of Minimally Invasive Techniques

The growing adoption of minimally invasive techniques is another key driver of the Global Peripheral Intervention Market Industry. Peripheral intervention procedures are typically less invasive than traditional open surgery, resulting in reduced trauma, pain, and recovery time for patients. This has led to a shift towards minimally invasive techniques, such as endovascular interventions, which involve accessing the affected arteries through a small incision in the groin or arm.The increasing popularity of these techniques is expected to contribute to the growth of the peripheral intervention market over the forecast period.

## **Peripheral Intervention Market Segment Insights**

### **Peripheral Intervention Market Intervention Type Insights**

The Global Peripheral Intervention Market revenue is projected to grow significantly over the next few years, driven by the rising prevalence of peripheral artery disease (PAD) and other vascular conditions. The market is segmented into various categories, including intervention type, end-user, and geography. Intervention Type The peripheral intervention market is segmented into five primary intervention types: atherectomy, stent implantation, angioplasty, thrombectomy, and embolization. Atherectomy: Atherectomy involves removing plaque from the arteries using a specialized catheter.It is commonly used to treat severe blockages in the arteries of the legs and arms.

The global atherectomy market is estimated to reach USD 1.2 billion by 2032, growing at a CAGR of 7.5%. 

Stent Implantation: Stent implantation involves placing a stent in the artery to keep it open. Stents are commonly used to treat blockages in the arteries of the legs, neck, and heart. The global stent implantation market is projected to surpass USD 2.5 billion by 2032, growing at a CAGR of 8.2%. Angioplasty: Angioplasty is a procedure that widens narrowed arteries using a balloon catheter.It is commonly used to treat blockages in the arteries of the legs, arms, and heart. The global angioplasty market is projected to reach USD 4.2 billion by 2029, growing at a CAGR of 7.8%.

Thrombectomy: Thrombectomy involves removing blood clots from the arteries using a specialized catheter. It is commonly used to treat blockages in the arteries of the legs, arms, and brain. The global thrombectomy market is projected to grow to USD 1.1 billion by 2032, growing at a CAGR of 8.1%. Embolization: Embolization involves blocking blood flow to a specific area of the body using a specialized catheter.It is commonly used to treat bleeding and to shrink tumors. The global embolization market is projected to reach USD 1.3 billion by 2032, growing at a CAGR of 8.0%.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Peripheral Intervention Market Device Type Insights**

Device Type Segment Insights and Overview The Global Peripheral Intervention Market is segmented into catheters, stents, guide wires, balloons, and embolic coils based on device type. Among these, the catheters segment held the largest market share in 2023 and is projected to maintain its dominance throughout the forecast period. The growth of this segment can be attributed to the increasing prevalence of peripheral artery disease (PAD), which requires catheter-based interventions for diagnosis and treatment.

The stents segment is expected to witness significant growth over the forecast period due to the rising demand for minimally invasive procedures and the development of advanced stents with improved functionality and durability.Guide wires, balloons, and embolic coils are also witnessing increasing adoption, driven by advancements in technology and the growing number of interventional procedures performed for various peripheral vascular diseases.

### **Peripheral Intervention Market Indication Insights**

The Global Peripheral Intervention Market segmentation by Indication includes Coronary Artery Disease, Stroke, Peripheral Arterial Disease, Renal Artery Stenosis, and Carotid Artery Stenosis. Coronary Artery Disease is expected to hold the largest market share due to its high prevalence and increasing adoption of minimally invasive procedures. Peripheral Arterial Disease is projected to grow at the highest CAGR during the forecast period owing to rising awareness and advancements in treatment options. This growth is attributed to factors such as the increasing prevalence of cardiovascular diseases, technological advancements, and favorable reimbursement policies.

### **Peripheral Intervention Market Technology Insights**

The Global Peripheral Intervention Market is segmented by Technology into Drug-Eluting Stents, Balloon-Expandable Stents, Self-Expanding Stents, Rotational Atherectomy, and Directional Atherectomy. Among these, Drug-Eluting Stents held the largest market share of 35.7% in 2023 and is expected to reach USD 4.2 billion by 2032, exhibiting a CAGR of 7.9% during the forecast period. The growth of this segment can be attributed to the increasing prevalence of peripheral artery disease and the benefits offered by drug-eluting stents, such as reduced restenosis rates and improved patency.Balloon-expandable stents are another major segment, accounting for a market share of 30.2% in 2023.

The increasing adoption of minimally invasive procedures and the availability of advanced balloon-expandable stents are driving the growth of this segment. Self-expanding stents, Rotational Atherectomy, and Directional Atherectomy are other important segments in the Global Peripheral Intervention Market, with each holding a significant market share. The growth of these segments is driven by factors such as technological advancements and the rising demand for minimally invasive procedures.

### **Peripheral Intervention Market End-User Insights**

The end-user segment of the Global Peripheral Intervention Market encompasses a diverse range of healthcare facilities that utilize peripheral intervention procedures to diagnose and treat vascular diseases. Key end-users include hospitals, ambulatory surgical centers, clinics, and research institutes. Hospitals account for a significant portion of the Global Peripheral Intervention Market revenue, driven by their comprehensive infrastructure, advanced medical equipment, and expertise in complex procedures. In 2023, hospitals held a dominant market share of approximately 65%.Ambulatory surgical centers, which offer less invasive procedures in an outpatient setting, are also gaining popularity, contributing to the market growth.

Clinics, often specialized in vascular care, play a crucial role in patient diagnosis and follow-up care. Research institutes contribute to the advancement of peripheral intervention techniques and technologies, driving innovation in the industry.

### **Peripheral Intervention Market Regional Insights**

The Global Peripheral Intervention Market is segmented into North America, Europe, APAC, South America, and MEA. North America is the largest region in the market, accounting for over 40% of the global revenue in 2023. The region is expected to continue to dominate the market throughout the forecast period, driven by factors such as the increasing prevalence of peripheral artery disease (PAD) and the rising demand for minimally invasive procedures.

Europe is the second-largest region in the market, accounting for over 30% of the global revenue in 2023.The region is expected to grow at a steady pace over the forecast period, driven by factors such as the increasing adoption of advanced technologies and the growing awareness of peripheral artery disease.

APAC is the third-largest region in the market, accounting for over 20% of the global revenue in 2023. The region is expected to witness significant growth over the forecast period, driven by factors such as rising disposable income and the increasing prevalence of chronic diseases. South America and MEA are emerging markets in the global peripheral intervention market.These regions are expected to grow at a rapid pace over the forecast period, driven by factors such as the increasing population and the growing demand for healthcare services.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Peripheral Intervention Market Key Players And Competitive Insights**

Major players in the Peripheral Intervention Market are continuously innovating new technologies and launching advanced products to cater to the growing needs of healthcare providers and patients alike. Leading Peripheral Intervention Market players have adopted various strategies, such as acquisitions, collaborations, and partnerships, to strengthen their market position and expand their product offerings. The Peripheral Intervention Market industry is characterized by intense competition, with several established and emerging players competing for market share.

The competitive landscape is expected to remain dynamic, with new entrants and technological advancements shaping the future of the market.Boston Scientific Corporation, a leading player in Peripheral Intervention Market development, has a strong portfolio of products and technologies for treating peripheral arterial diseases. 

The company's focus on innovation and commitment to providing high-quality solutions has enabled it to maintain a leading position in the market. Boston Scientific Corporation has a global presence and a well-established distribution network, which provides it with a competitive advantage. The company's continued investments in research and development are expected to further strengthen its market position.Medtronic plc, a major competitor in the Peripheral Intervention Market Competitive Landscape, offers a comprehensive range of peripheral intervention devices and technologies. The company's focus on developing innovative solutions for treating vascular diseases has helped it gain a significant market share.

Medtronic plc has a strong brand reputation and a global distribution network, which provides it with a competitive advantage. The company's continued investments in research and development are expected to further strengthen its market position.

### **Key Companies in the Peripheral Intervention Market Include**

## **Peripheral Intervention Market Industry Developments**

The Peripheral Intervention market is poised to grow significantly over the forecast period, driven by the rising prevalence of peripheral artery diseases, increasing adoption of minimally invasive procedures, and technological advancements. The market is expected to reach a valuation of USD 11.9 billion by 2032, exhibiting a CAGR of 7.77% from 2025 to 2034. Key developments in the market include the launch of innovative devices such as drug-coated balloons and bioresorbable scaffolds, as well as strategic collaborations and acquisitions among market players.

## **Peripheral Intervention Market Segmentation Insights**

### **Peripheral Intervention Market Intervention Type Outlook**

### **Peripheral Intervention Market Device Type Outlook**

### **Peripheral Intervention Market Indication Outlook**

### **Peripheral Intervention Market Technology Outlook**

### **Peripheral Intervention Market End-User Outlook**

### **Peripheral Intervention Market Regional Outlook**

## Market Drivers

### Focus on Personalized Medicine

向[个性化医疗](https://www.marketresearchfuture.com/reports/personalized-medicine-market-2937)的趋势正在显著影响周边介入市场。根据个体患者的需求量身定制治疗方案，提高了干预的有效性并改善了整体结果。这种方法在血管疾病的背景下尤为相关，因为患者特定的因素，如遗传、生活方式和合并症，在治疗成功中起着至关重要的作用。 
 
市场正在见证针对这些独特患者特征的定制设备和疗法的发展增加。随着医疗系统越来越多地采用个性化策略，周边介入市场可能会看到对与这一趋势相一致的创新解决方案的需求激增。这一转变不仅增强了患者护理，还推动了市场增长，因为利益相关者在研发上投资，以创造更有效的个性化治疗选择。

### Government Initiatives and Funding

政府倡议和资金在塑造周边介入市场中至关重要。各健康机构正在认识到解决血管疾病的重要性，并分配资源以改善治疗的可及性和结果。例如，用于新型周边介入技术的研究和开发的资金正在增加，多个国家正在实施旨在增强医疗基础设施的项目。
 
这些倡议可能会刺激市场内的创新，鼓励公司开发先进的设备和疗法。此外，旨在提高公众对血管健康意识的公共卫生运动预计将增加患者参与和对干预的需求。因此，周边介入市场将从这些支持性的政府行动中受益，这可能导致市场环境更加稳健和动态。

### Aging Population and Lifestyle Changes

老龄化人口与生活方式变化是推动周边介入市场的重要因素。随着个体年龄的增长，发展血管疾病的风险增加，迫切需要有效的干预策略。此外，久坐行为、不良饮食和糖尿病的普遍增加等生活方式因素也在促进血管疾病的上升。
 
数据显示，到2030年，65岁及以上的人口预计将达到15亿，创造出对周边干预的巨大需求。这一人口结构的变化促使医疗提供者关注预防措施和先进治疗选择。因此，周边介入市场可能会随着其适应老龄化人口的需求而扩展，强调创新解决方案在应对这些生活方式变化带来的挑战中的重要性。

### Rising Prevalence of Vascular Diseases

血管疾病的发病率上升是推动周边介入市场的关键因素。外周动脉疾病（PAD）和慢性静脉功能不全等疾病在老龄化人群中变得越来越普遍。数据显示，仅在美国，就有大约800万到1200万人受到PAD的影响，突显出需要干预的庞大患者基础。
 
这种日益普遍的情况促使医疗提供者寻求先进的治疗选择，从而推动对周边介入设备的需求。随着人们对血管健康意识的不断提高，市场可能会扩展，强调有效应对这些疾病的创新解决方案。因此，周边介入市场有望从这一人口结构变化中受益，越来越多的患者寻求及时和有效的干预。

### Technological Advancements in Peripheral Intervention

由于快速的技术进步，周边介入市场正在经历显著的转变。微创技术、先进成像方式和生物可吸收支架的发展等创新正在改善程序结果。例如，机器人辅助设备的引入正在简化复杂的干预，从而减少恢复时间并提高患者满意度。
 
根据最新数据，[周边血管设备](https://www.marketresearchfuture.com/reports/peripheral-vascular-device-market-30187)的市场预计到2026年将达到80亿美元，这得益于这些技术创新。此外，人工智能在成像和诊断中的应用可能会提高干预的精确性，使其更安全、更有效。这一趋势表明，周边介入市场正朝着更复杂和高效的治疗选择转变。

## Future Outlook

外周介入市场预计在2025年至2035年期间以7.77%的年均增长率增长，推动因素包括技术进步、血管疾病的流行率增加以及医疗支出的上升。

**New opportunities:**

- 开发先进的药物洗脱支架以改善患者的治疗效果。

到2035年，外周介入市场预计将实现显著增长，反映出不断变化的医疗需求。

## Segment Insights

### 按干预类型：动脉切除术（最大）与支架植入（增长最快）

外周干预市场分为五种主要干预类型：动脉切除术、支架植入、血管成形术、血栓切除术和栓塞术。动脉切除术目前占据最大的市场份额，因为它在去除动脉内斑块方面的有效性，使其成为医疗专业人员的首选。相反，尽管支架植入的市场份额不大，但由于技术进步增强了支架的输送和材料确保了更好的患者结果，它正在迅速获得关注，成为增长最快的细分市场。

动脉切除术（主导）与支架植入（新兴）

动脉切除术在外周干预市场中作为主导细分市场，主要由于其独特的能力去除动脉粥样硬化斑块，从而有效恢复血流。其在治疗外周动脉疾病中的使用在血管外科医生中获得了显著认可。另一方面，支架植入由于支架设计和生物工程材料的创新，正在成为一个竞争性细分市场，促进了更快的恢复。心血管疾病的发病率不断上升推动了需求，使支架植入在介入程序中成为一个有吸引力的选择。随着这些细分市场的发展，它们突显了外周干预的动态和竞争格局。

### 按设备类型：导管（最大）与支架（增长最快）

外周干预市场在各种设备类型中表现出多样化的分布。导管由于在众多干预中的广泛使用，特别是在治疗血管问题和诊断程序中，占据最大的市场份额。支架虽然市场份额较小，但由于在微创手术中发挥着关键作用，特别是在治疗冠状动脉疾病方面，正在迅速获得关注。其他细分市场如导丝、气球和栓塞线圈也占据重要位置，凭借其独特的功能为外周干预的整体有效性做出贡献。

导管（主导）与支架（新兴）

导管在外周干预市场中仍然是一个主导力量，以其多功能性和在各种医疗程序（如血管成形术和血管通路）中的重要作用而闻名。其广泛使用受到材料和技术持续进步的推动，这些进步提高了性能和患者结果。另一方面，支架由于在介入后维持血管通畅的关键功能而正在成为重要参与者。随着技术的发展，特别是药物洗脱支架的引入，它们在治疗血管疾病中变得越来越重要，为未来几年的加速增长奠定了基础。

### 按适应症：冠状动脉疾病（最大）与中风（增长最快）

在外周干预市场中，适应症细分主要由冠状动脉疾病主导，在各种适应症中占据最大的市场份额。紧随其后的是外周动脉疾病、肾动脉狭窄和颈动脉狭窄等其他疾病，这些疾病在整体市场格局中发挥着关键作用。中风虽然市场份额较小，但由于技术进步和对其治疗选择的认识不断提高，正在获得关注。该细分市场的增长趋势突显了动态转变，中风正在成为增长最快的适应症，推动因素包括发病率上升和对及时干预的需求。改进的诊断技术、老年人口的增加和创新治疗方法等因素正在推动市场向前发展。同时，持续关注冠状动脉疾病的管理确保了持续的需求，使其在市场中占据了重要地位，医疗系统努力实现更好的患者结果。

冠状动脉疾病（主导）与中风（新兴）

冠状动脉疾病以显著的流行率为特征，使其成为外周干预市场中的主导适应症，因其长期的认可和既定的治疗方案而受到重视。对这一细分市场的关注主要是由于有效管理心血管健康所需的预防和干预措施。相比之下，中风被视为一个新兴细分市场，反映了对治疗选择的认识增加和技术进步，这些都促进了其快速增长。技术创新的激增，例如微创手术和血栓切除设备，进一步支持了这一增长。总的来说，尽管冠状动脉疾病仍然是一个支柱，中风正准备在获得动力的同时重塑外周干预的格局。

### 按技术：药物洗脱支架（最大）与自扩张支架（增长最快）

在外周干预市场中，药物洗脱支架由于其在降低再狭窄率方面的有效性而占据最大的市场份额。这些支架释放抑制组织生长的药物，从而为患者带来更好的长期结果。紧随其后的是自扩张支架，由于其适应性和在各种血管解剖结构中的易于放置而获得关注，吸引了越来越多寻求治疗灵活性的医疗提供者。

技术：药物洗脱支架（主导）与自扩张支架（新兴）

药物洗脱支架因其在外周干预市场中的主导地位而受到认可，主要是因为它们改善了患者结果并显著降低了再狭窄率。它们的设计集成了针对特定组织的药物释放机制，这在维持血管通畅方面特别有效。相比之下，自扩张支架由于其独特的能力能够适应动脉的大小和形状而正在崭露头角，使其成为处理非典型病变的理想选择。由于材料技术的进步和易于输送的特点，它们在介入心脏病学家中越来越受欢迎。

### 按最终用户：医院（最大）与门诊手术中心（增长最快）

在外周干预市场中，医院在最终用户中占据最大的市场份额，因为它们拥有全面的设施和专业护理的可用性。它们是进行复杂干预的主要机构，这显著促进了它们的市场主导地位。另一方面，门诊手术中心作为一个重要参与者出现，吸引寻求门诊手术的患者。细分市场的分布表明，尽管医院占据了市场的相当一部分，但其他医疗设施，如诊所和研究机构，也为该领域的整体动态做出了贡献。

医院（主导）与门诊手术中心（新兴）

医院是外周干预市场中的主导最终用户，以其先进的外科能力和专业医疗人员为特征。它们提供一系列外周干预，并配备最先进的技术，营造出适合复杂程序的环境。相比之下，门诊手术中心正在成为微创手术的首选，提供如成本较低和恢复时间更快等好处。它们能够容纳日间手术，使其能够满足寻求高效护理的日益增长的患者群体。随着医疗环境的发展，这两个细分市场发挥着关键作用，医院继续领先，门诊手术中心迅速获得关注。

## Regional Market Share Analysis

### 北美：创新市场领导者

北美是外周介入的最大市场，占全球份额的约45%。增长受到老龄化人口、外周动脉疾病流行率上升和医疗技术进步的推动。FDA等机构的监管支持也催化了创新和新设备的市场进入，改善了患者结果并扩展了治疗选择。

美国是主要贡献者，主要参与者如美敦力、波士顿科学和雅培实验室在市场中处于领先地位。竞争格局的特点是这些公司之间的持续创新和战略合作伙伴关系。先进的医疗基础设施和高医疗支出进一步巩固了北美作为外周介入技术中心的地位。

### 欧洲：具有增长潜力的新兴市场

欧洲是外周介入的第二大市场，约占全球市场份额的30%。该地区由于对外周疾病的认识提高、良好的报销政策和强大的监管框架而见证了增长。欧洲药品管理局（EMA）在简化新设备的批准流程方面发挥了重要作用，从而鼓励了创新和市场进入。

主要国家包括德国、法国和英国，这些国家在医疗技术方面进行了重大投资。主要参与者如B. Braun Melsungen AG和飞利浦正在扩大其产品供应，以满足日益增长的需求。竞争格局以合作和合并为特征，增强了公司提供外周介入先进解决方案的能力。

### 亚太地区：快速增长的市场

亚太地区正在迅速崛起为外周介入市场的重要参与者，约占全球份额的20%。增长受到医疗支出上升、慢性疾病流行率上升和老年人口增长的推动。中国和印度等国对先进医疗技术的需求激增，政府倡导改善医疗服务的举措得到了支持。

中国是该地区最大的市场，竞争格局中既有本地企业也有国际企业。像Terumo Corporation和Cook Medical这样的公司正在扩大其市场份额，专注于满足区域需求的创新解决方案。市场的特点是成熟公司和新进入者的混合，促进了增长和发展的动态环境。

### 中东和非洲：未开发的市场潜力

中东和非洲地区在外周介入市场中逐渐崭露头角，占全球份额的约5%。增长主要受到医疗投资增加、对外周疾病认识提高和医疗基础设施改善的推动。各国政府正专注于改善医疗服务，预计将推动未来几年对先进医疗设备的需求。

该地区的主要国家包括南非和阿联酋，国际参与者的存在日益增长。公司越来越多地投资于本地合作伙伴关系，以增强市场覆盖率。竞争格局正在演变，重点是创新解决方案和改善患者护理，使该地区成为未来外周介入增长的潜在热点。

## Competitive Benchmarking

外周介入市场的竞争格局动态，受到技术进步、外周血管疾病流行率上升和老年人口增长的推动。美敦力（美国）、波士顿科学（美国）和雅培实验室（美国）等主要参与者在战略上定位，以利用创新并扩大市场份额。美敦力（美国）专注于通过持续创新增强其产品组合，而波士顿科学（美国）则强调战略合作伙伴关系以增强其技术能力。雅培实验室（美国）积极追求区域扩张，特别是在新兴市场，这共同塑造了一个越来越依赖创新和战略合作的竞争环境。外周介入市场的主要商业策略包括本地化制造和优化供应链，以提高运营效率。市场结构似乎适度分散，几个主要参与者对各个细分市场施加影响。这种分散使得产品和服务的多样化得以实现，促进了推动创新的竞争。这些主要参与者的集体影响力显著，因为他们不断适应市场需求和监管变化，从而塑造整体竞争动态。
在八月，美敦力（美国）宣布推出其下一代外周气囊导管，该导管结合了先进的药物输送技术。这一战略举措可能会改善患者结果，并巩固美敦力在外周介入领域的领导地位。这一创新产品的推出与公司解决未满足医疗需求的承诺相一致，并展示了其对研究和开发的关注。
在九月，波士顿科学（美国）与一家领先的数字健康公司建立了合作伙伴关系，将基于人工智能的分析集成到其外周介入设备中。这一合作预计将增强其产品的功能，为临床医生提供实时数据以改善患者管理。这一合作的战略重要性在于其潜力可以彻底改变外周介入的执行方式，从而使波士顿科学在市场技术进步的前沿。
在七月，雅培实验室（美国）在亚洲扩大了其制造能力，以满足对外周介入设备日益增长的需求。这一扩展不仅增强了雅培的供应链韧性，还允许更快地响应市场需求。这一举措的战略重要性在于该地区对创新解决方案的需求日益增长，雅培旨在通过本地化生产来利用这一机会。
截至十月，当前外周介入市场的竞争趋势受到数字化、可持续性和人工智能整合的强烈影响。战略联盟越来越多地塑造市场格局，因为公司认识到合作在推动创新中的价值。展望未来，竞争差异化可能会从传统的基于价格的竞争转向关注技术创新、改善患者结果和供应链可靠性。这一转变强调了在市场中保持竞争优势的适应性和前瞻性战略的重要性。

## Recent News & Developments

在2026年7月，雅培获得FDA批准其Esprit BTK依维莫司释放可吸收支架系统的更长版本（76mm），这是首个用于治疗膝下慢性肢体威胁缺血（CLTI）的可溶解支架，随后在2026年8月在欧洲获得CE标志。这扩展了对最严重形式的外周动脉疾病的治疗选择，患者之前只有气囊成形术可用，但长期通畅性差；可溶解设计不留永久植入物。（来源：[vascularnews.com](https://vascularnews.com/tag/pad/)）

在2026年5月，波士顿科学宣布其关键FRACTURE IDE试验的积极结果，该试验评估了用于严重钙化冠状动脉疾病的实验性SEISMIQ 4CE冠状动脉血管内碎石导管，该导管与公司在2025年获得FDA批准的SEISMIQ IVL外周导管使用相同的控制台。这验证并扩展了波士顿科学的核心IVL钙修改平台（通过在2025年收购Bolt Medical获得），将其从外周疾病延伸到冠状动脉疾病，巩固了其在外周和冠状动脉护理中最快增长的设备细分市场中的地位。（来源：[news.bostonscientific.com](https://news.bostonscientific.com/2026-05-19-FRACTURE-IDE-trial-of-the-Boston-Scientific-SEISMIQ-TM-4CE-Coronary-Intravascular-Lithotripsy-Catheter-meets-primary-safety-and-effectiveness-endpoints)）

在2026年4月，美敦力完成了对CathWorks Ltd.的收购，这是一家专注于诊断和治疗冠状动脉疾病的私人医疗设备公司，增强了其冠状动脉和外周血管（CPV）部门。这扩展了美敦力在冠状动脉和外周血管诊断和治疗能力的结合，该部门也因外周血管健康产品如IN.PACT Admiral和静脉内产品而蓬勃发展。（来源：[SEC.gov, Medtronic FY2026 10-K](https://www.sec.gov/Archives/edgar/data/0001613103/000162828026044354/mdt-20260424.htm)）

## Report Scope

| 2024年市场规模 | 70.47（亿美元） |
| --- | --- |
| 2025年市场规模 | 75.95（亿美元） |
| 2035年市场规模 | 160.5（亿美元） |
| 年均复合增长率（CAGR） | 7.77%（2025 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 亿美元 |
| 主要公司简介 | 美敦力（美国）、波士顿科学（美国）、雅培实验室（美国）、B. Braun Melsungen AG（德国）、Terumo Corporation（日本）、Cook Medical（美国）、Cardinal Health（美国）、强生（美国）、飞利浦（荷兰） |
| 覆盖的细分市场 | 介入类型、设备类型、适应症、技术、最终用户、区域 |
| 主要市场机会 | 微创技术的进步增强了外周介入市场的增长潜力。 |
| 主要市场动态 | 技术进步和监管变化推动外周介入市场的创新和竞争。 |
| 覆盖的国家 | 北美、欧洲、亚太地区、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 到2035年，外周介入市场的预计市场估值是多少？**
A: 外周介入市场预计到2035年将达到160.5亿美元的估值。

**Q: 2024年外周介入市场的市场估值是多少？**
A: 在2024年，外周介入市场的估值为70.47亿美元。

**Q: 在2025年至2035年的预测期内，外周介入市场的预期年均增长率（CAGR）是多少？**
A: 在2025年至2035年的预测期内，外周介入市场的预期年均增长率为7.77%。

**Q: 哪些公司被视为外周介入市场的关键参与者？**
A: 外周介入市场的关键参与者包括美敦力、波士顿科学、雅培实验室等。

**Q: 到2035年，动脉切除术细分市场的预计收入是多少？**
A: 动脉切除术细分市场预计到2035年将产生9亿至21亿美元的收入。

**Q: 支架植入细分市场在市场估值方面表现如何？**
A: 支架植入细分市场预计将从25亿美元增长到55亿美元，到2035年。

**Q: 到2035年，外周介入市场中导管的预期市场规模是多少？**
A: 导管细分市场预计到2035年将达到35亿美元的市场规模。

**Q: 到2035年，药物洗脱支架技术的预期收入范围是多少？**
A: 药物洗脱支架技术预计将产生25亿至55亿美元的收入，到2035年。

**Q: 到2035年，哪个最终用户细分市场预计将主导外周介入市场？**
A: 医院细分市场预计将主导外周介入市场，预计收入在25亿至55亿美元之间，到2035年。

**Q: 哪些指征推动了外周介入市场的增长？**
A: 冠状动脉疾病和中风等指征推动了增长，预计到2035年分别产生55亿美元和35亿美元的收入。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/peripheral-intervention-market-30173*